CADM1 and laryngeal squamous cell carcinoma: In humans, hsa-miR-424-5p was reported to be upregulated in laryngeal squamous cell carcinoma and promoted proliferation, migration, and invasion by targeting the tumor suppressor, CADM1 [40].